Investigational malaria vaccine found safe and protective
NIH vaccine researchers publish results of early-stage clinical trial
An investigational malaria vaccine has been found to be safe, to generate an immune system response, and to offer protection against malaria infection in healthy adults, according to the results of an early-stage clinical trial.
This page was last updated on Friday, January 21, 2022